About anika therapeut - ANIK
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
ANIK At a Glance
Anika Therapeutics, Inc.
32 Wiggins Avenue
Bedford, Massachusetts 01730
| Phone | 1-781-457-9000 | Revenue | 112.82M | |
| Industry | Medical Specialties | Net Income | -10,880,000.00 | |
| Sector | Health Technology | Employees | 235 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
ANIK Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.221 |
| Price to Book Ratio | 0.93 |
| Price to Cash Flow Ratio | 12.32 |
| Enterprise Value to EBITDA | -20.023 |
| Enterprise Value to Sales | 0.945 |
| Total Debt to Enterprise Value | 0.246 |
ANIK Efficiency
| Revenue/Employee | 480,080.851 |
| Income Per Employee | -46,297.872 |
| Receivables Turnover | 4.762 |
| Total Asset Turnover | 0.54 |
ANIK Liquidity
| Current Ratio | 4.718 |
| Quick Ratio | 3.86 |
| Cash Ratio | 2.624 |
ANIK Profitability
| Gross Margin | 56.557 |
| Operating Margin | -9.795 |
| Pretax Margin | -8.249 |
| Net Margin | -9.644 |
| Return on Assets | -4.774 |
| Return on Equity | -6.71 |
| Return on Total Capital | -5.88 |
| Return on Invested Capital | -5.774 |
ANIK Capital Structure
| Total Debt to Total Equity | 18.296 |
| Total Debt to Total Capital | 15.466 |
| Total Debt to Total Assets | 12.966 |
| Long-Term Debt to Equity | 16.865 |
| Long-Term Debt to Total Capital | 14.257 |